Examining the ways and extent to which systemic factors affect health outcomes with regard to quality, affordability and access to curative healthcare, this explorative book compares tax-funded Beveridge systems and insurance-based Bismarck systems. Containing contributions from national experts, The Law and Policy of Healthcare Financing charts and compares the merits of healthcare systems throughout 11 countries, from the UK to Colombia.
Browse by title
Edited by Sherman Folland and Eric Nauenberg
Sherman Folland and Eric Nauenberg present the cutting edge of research covering the ever-expanding social capital field. With excellent contributions from leading academics, the Elgar Companion to Social Capital and Health offers a developed examination of new research across sociology, epidemiology, economics, psychology, and political science.
An Introduction to the Relationship between Inequality and Health
Andreas Bergh, Therese Nilsson and Daniel Waldenström
There is a clear trend in rich countries that despite rising incomes and living standards, the gap between rich and poor is widening. What does this mean for our health? Does increasing income inequality affect outcomes such as obesity, life expectancy and subjective well-being? Are rich and poor groups affected in the same ways? This book reviews the latest research on the relationship between inequality and health. It provides the reader with a pedagogical introduction to the tools and knowledge required to understand and assess the issue. Main conclusions from the literature are then summarized and discussed critically.
Edited by Neil Lunt, Daniel Horsfall and Johanna Hanefeld
The growth of international travel for purposes of medical treatment has been accompanied by increased academic research and analysis. This Handbook explores the emergence of medical travel and patient mobility and the implications for patients and health systems. Bringing together leading scholars and analysts from across the globe, this unprecedented Handbook examines the regional and national experiences of medical tourism, including coverage of the Americas, Europe, Africa, the Middle East, and Asia. The chapters explore topics on issues of risk, law and ethics; and include treatment-focused discussions which highlight patient decision-making, patient experience and treatment outcomes for cosmetic, transplantation, dentil, fertility and bariatric treatment.
Ritsa Fotinatos-Ventouratos and Cary Cooper
The global economic crisis of 2008 caused the collapse of the world’s financial institutions, large-scale unemployment, the devaluing of housing stocks leading to mortgage defaults and left many countries in debt, unable to meet their financial obligations. The consequences of this in the workplace were substantial and for those who remained employed, longer working hours, heavier workloads, an insecure working environment and micro-management became manifest. Examining the impact of the recession on organizations and individuals at work, this book explores the long lasting effect the crisis will have on workplaces for the future. An insightful and thorough account of how the economic crisis has unfolded on an international scale is presented and the profound psychological impact that this recession has had on the workplace assessed.
Robert J. Brent
Cost–benefit analysis is the only method of economic evaluation that can effectively indicate whether a health care treatment or intervention is worthwhile. In this thoroughly updated and revised second edition, Robert Brent expands the scope of the field by including the latest concepts and applications throughout all regions of the world. This book attempts to strengthen the link between cost–benefit analysis and the mainstream health care evaluation field, which is dominated by non-economists. The need to build a bridge between the two is more important than ever before, as the general understanding of cost-benefit analysis appears to have regressed.
Sarah Harper, Kate Hamblin, Jaco Hoffman, Kenneth Howse and George Leeson
The International Handbook on Ageing and Public Policy explores the challenges arising from the ageing of populations across the globe for government, policy makers, the private sector and civil society. It examines various national state approaches to welfare provisions for older people, and highlights alternatives based around the voluntary and third-party sector, families and private initiatives. The Handbook is highly relevant for academics interested in this critical issue, and offers important messages for policy makers and practitioners.
Anthony J. Culyer
This third edition of Anthony Culyer’s authoritative The Dictionary of Health Economics brings the material right up to date as well as adding plentiful amounts of new information, with a number of revised definitions. There are now nearly 3,000 entries in this comprehensive work. This third edition includes 250 new references as sources for definitions and examples of practice and the bibliography comprises roughly 1,400 items. Anthony Culyer has refined and made the system of cross-references and internet links even more comprehensive than in previous editions. This Dictionary is as complete a statement as exists anywhere of what it is that every health economist ought to know.
Economics, Ethics and Public Policy
Once exports and imports meant agriculture and industry. Today, in the global economy and the electronic age, trade is also expanding into the service sector. This timely book closely examines trade in health. Professor David Reisman offers a comprehensive and searching multidisciplinary account of the way in which medical services, patients, capital and professionals make up a global healthcare economy that crosses borders. Combining theory and empirical evidence from economics, tourism, and medical care, scholars involved in health economics and social administration will find much of significance in this authoritative study.
William S. Comanor and Stuart O. Schweitzer
Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for pharmaceuticals. Further sections discuss topics including demand and incentives, pricing and regulation.